Ignite Creation Date:
2024-05-06 @ 3:53 AM
Last Modification Date:
2024-10-26 @ 11:40 AM
Study NCT ID:
NCT02401347
Status:
COMPLETED
Last Update Posted:
2023-02-21
First Post:
2015-03-24
Brief Title:
Phase II Trial of Talazoparib in BRCA12 Wild-type HER2-negative Breast Cancer and Other Solid Tumors
Sponsor:
Melinda Telli
Organization:
Stanford University
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-08
Start Date Type:
ACTUAL
Primary Completion Date:
2019-12-23
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-12
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-24
First Submit QC Date:
March 24 2015
Study First Post Date:
2015-03-27
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2023-02-21
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-02-16
Last Update Post Date:
2023-02-21
Last Update Post Date Type:
ACTUAL